Dietary Reference Intakes based on chronic disease endpoints: outcomes from a case study workshop for omega 3’s EPA and DHA
| Autor: | Richard P. Bazinet, Ken D. Stark, Amanda J. MacFarlane, Megan Racey, Allison A. Yates, George A. Wells, Andrea Grantham, Mélanie Plourde, David W.L. Ma, Susan E. Carlson, Catherine J. Field |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Aging
Canada Biomedical Research Docosahexaenoic Acids Physiology Endocrinology Diabetes and Metabolism 030204 cardiovascular system & hematology Recommended Dietary Allowances Health outcomes 03 medical and health sciences Child Development 0302 clinical medicine Pregnancy Risk Factors Physiology (medical) Environmental health Humans Medicine 030212 general & internal medicine Child Inflammation Nutrition and Dietetics business.industry Immunity Brain Infant General Medicine Eicosapentaenoic acid Diet Pregnancy Complications Chronic disease Eicosapentaenoic Acid Cardiovascular Diseases Dietary Reference Intake Chronic Disease Premature Birth Female lipids (amino acids peptides and proteins) business Long chain |
| Zdroj: | Applied Physiology, Nutrition, and Metabolism. 46:530-539 |
| ISSN: | 1715-5320 1715-5312 |
| DOI: | 10.1139/apnm-2020-0994 |
| Popis: | Given the focus on developing Dietary Reference Intakes (DRIs) based on chronic disease risk reduction and recent research for omega-3 long chain PUFA since the last DRI review, the Canadian Nutrition Society convened a panel of stakeholders for a 1-day workshop in late 2019. Attendees discussed the new NASEM guidelines for establishing DRI values based on chronic disease risk endpoints and the strength of current evidence for EPA and DHA as it relates to the new guidelines. Novelty: Summarizes evidence and expert opinions regarding the potential for reviewing DRI values for EPA and DHA and cardiovascular disease risk and early development. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|